NCT07250997Recruiting
PALLAS Laser for Skin Diseases
Study of the Effectiveness of the PALLAS Laser in the Treatment of Skin Diseases That Respond Well to UV Light
Source: ClinicalTrials.gov · Last updated 6 Feb 2026
Brief summary (registry, in English)
The primary objective of this study is to get clinical experiences with the PALLAS laser in the treatment of skin conditions that respond well to UV light (vitiligo, psoriasis, alopecia areata, atopic dermatitis). The secondary objective is to assess how user-friendly is the Pallas laser in the treatment of skin diseases. The patient in the trial will receive UVB laser treatment (2 treatments per week for up to 3 months). The treatments will be carried out by the doctors participating in the trial. The treatment takes approximately 10 minutes per session, and can last up to 3 months per patient. Photographic documentation of the lesions to be treated and the lesions treated is taken at the start of the examination and then once a month. At the end of the study, the patient rates the treatment and improvement on a Patient Satisfaction Scale.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 23 Sept 2025
- Start date
- Dec 2025
- Primary completion date
- Dec 2026
- Lead sponsor
- Szeged University
- Diseases
- Atopic dermatitis (eczema), Psoriasis
- NCT number
- NCT07250997
What you commit to
- Study type: Interventional
- Planned participants: 50
- From Dec 2025 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- epilepsy,
- fever, infectious diseases,
Age
- Patient under 18 years of age,
Other
- pregnancy
- the patient is within one month or currently enrolled in another clinical trial.
Who the study is looking for
- The subject understands the information provided, gives informed consent to participate in the study and is deemed by the investigator to be able to participate,
- a skin condition that is expected to respond well to targeted UVB treatment,
- a signed consent form.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Szeged, Albert Szent-Györgyi Clinical Centre, Department of Dermatology and Allergology Coordinator of this site? Confirm its status | Szeged | Hungary | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.